Behavioral and biochemical effects of intranigral injection of phospholipase-A2.
Cadet
J L
JL
Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Hu
M
M
Jackson-Lewis
V
V
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D010740:Phospholipases / Q000494:pharmacology*; D010741:Phospholipases A / Q000494:pharmacology*; D054467:Phospholipases A2; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects*; D013378:Substantia Nigra / Q000187:drug effects*
D011954:Receptors, Dopamine; D015102:3,4-Dihydroxyphenylacetic Acid; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; D001058:Apomorphine; D004298:Dopamine; D006719:Homovanillic Acid